Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
08/31/1995 | WO1995022974A2 Film coated tablet of paracetamol and domperidone |
08/31/1995 | WO1995022963A1 Drug targeting system, method for preparing same and its use |
08/31/1995 | WO1995022962A1 Controlled release composition |
08/31/1995 | WO1995022950A1 Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters |
08/31/1995 | DE4406073A1 Verfahren zur Herstellung von humanen, klonogenen Fibroblasten, Verfahren zur Gentransfizierung von Fibroblasten und so erhaltene Fibroblasten A process for the production of human, clonogenic fibroblasts method for Gentransfizierung of fibroblasts and fibroblasts thus obtained |
08/31/1995 | DE4405545A1 Oral vitamin compsn. with improved resorption |
08/31/1995 | CA2184198A1 Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters |
08/31/1995 | CA2184176A1 Method for stimulating profileration of colon cells using pomc76-103 |
08/31/1995 | CA2184002A1 Method and compositions for increasing the serum half-life of pharmacologically active agents |
08/31/1995 | CA2183766A1 Block copolymers |
08/31/1995 | CA2183535A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
08/31/1995 | CA2183438A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained |
08/31/1995 | CA2161343A1 Cyclosporin-containing powder composition |
08/30/1995 | EP0669131A1 Aquous concentrated solutions containing argatroban |
08/30/1995 | EP0669129A2 Expandable release controlled medicaments |
08/30/1995 | EP0668933A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
08/30/1995 | EP0668931A1 Nucleic acid ligands and methods for producing the same |
08/30/1995 | EP0668875A1 Clot directed anticoagulant, process for making same and methods of use |
08/30/1995 | EP0668871A1 Amino-acid sequence homologies between selectins and b. pertussis toxin-peptidesderived therfrom, antibodies thereto and pharmaceutical compositions |
08/30/1995 | EP0668774A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis |
08/30/1995 | EP0668759A1 Transdermal delivery of ketorolac |
08/30/1995 | EP0556239B1 Aerosol containing medicaments |
08/30/1995 | EP0542824B1 Method for preparing a bioadhesive galenical and galenical thereby obtained |
08/30/1995 | CN1107367A Stabilized pharmaceutical compositions and stabilizing solvent |
08/30/1995 | CN1107334A Oral medicine for reducing cholesterol |
08/29/1995 | US5446091 Collagen-polymer conjugates containing an ether linkage |
08/29/1995 | US5446090 Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
08/29/1995 | US5446070 Flexible, finite, bioadhesive, therapeutical agent in solid form |
08/29/1995 | US5446063 Anesthetic compositions |
08/29/1995 | US5446033 Stabilized hexadecylphosphocholine solutions in glycerol alkyl ethers |
08/29/1995 | US5446025 Formulations and method of the percutaneous administration of leuprolide |
08/29/1995 | US5446023 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems |
08/29/1995 | US5445832 Composition of sustained and controlled release of medicamentous peptide substances by converting water soluble peptide into a water insoluble peptide salt |
08/29/1995 | US5445828 Having hydrophobic layer of fatty acids, alcohols, esters, salts, glycerides, waxes, paraffin oil |
08/29/1995 | US5445827 Granules consisting of ibuprofen sodium salt, sodium hydrogen carbonate, polyvinylpyrrolidone, sodium carbonate, citric acid |
08/29/1995 | US5445826 Prolonged-release unit dosage formulation; includes a mineral salt which releases a physiologically-acceptable gas upon ingestion |
08/29/1995 | US5445817 Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines |
08/29/1995 | US5445813 Stable microbubble suspensions as enhancement agents for ultrasound echography |
08/29/1995 | US5445812 Angiographic adjuvant |
08/29/1995 | US5445811 Organ specific emulsion |
08/29/1995 | CA1336826C Chimeric antibody with specificity to human b cell surface antigen |
08/29/1995 | CA1336819C Orally administrable ibuprofen compositions |
08/24/1995 | WO1995022618A1 Nucleic acid delivery system, method of synthesis and uses thereof |
08/24/1995 | WO1995022617A1 Host-vector system for use in gene therapy |
08/24/1995 | WO1995022611A2 Methods and compositions for stimulating bone cells |
08/24/1995 | WO1995022351A1 Composition for topical application |
08/24/1995 | WO1995022347A1 Pharmaceutical preparation containing plasminogen activators |
08/24/1995 | WO1995022343A1 Cyclosporin-containing emulsion composition |
08/24/1995 | WO1995022335A1 Acidified nitrite as an antimicrobial agent |
08/24/1995 | WO1995022333A1 Process for producing a sterile prednisolone gel |
08/24/1995 | WO1995022331A1 Aqueous indolocarbazole solutions |
08/24/1995 | WO1995022325A1 Compositions containing micronized nebivolol |
08/24/1995 | WO1995022322A1 Sexual steroid-containing transdermal therapeutic systems |
08/24/1995 | WO1995022319A1 Process for preparing fine particle pharmaceutical formulations |
08/24/1995 | WO1995022318A1 Drugs, vaccines and hormones in polylactide coated microspheres |
08/24/1995 | WO1995022316A1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
08/24/1995 | WO1995022315A1 Liquid ophthalmic sustained release delivery system |
08/24/1995 | WO1995022310A1 Cosmetic compositions |
08/24/1995 | DE4405898A1 Transdermale therapeutische Systeme enthaltend Sexualsteroide Transdermal therapeutic systems containing sex steroids |
08/24/1995 | DE4405426A1 Pharmazeutisches Präparat enthaltend Plasminogenaktivator (t-PA) oder dessen Derivate A pharmaceutical preparation containing plasminogen activator (t-PA) or derivatives thereof |
08/24/1995 | CA2183667A1 Nucleic acid delivery system, method of synthesis and uses thereof |
08/23/1995 | EP0668354A1 Cysteine added variants of G-CSF and chemical modifications thereof |
08/23/1995 | EP0668353A1 Cysteine added variants of EPO and chemical modifications thereof |
08/23/1995 | EP0668349A2 Muteins of pancreatic ribonuclease and uses thereof |
08/23/1995 | EP0667901A1 Novel cytokine |
08/23/1995 | EP0667787A1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines |
08/23/1995 | EP0667779A1 Ophthalmic solution and method of use |
08/23/1995 | EP0667774A1 Transdermal therapeutic system for administering physostigmin through the skin, and a method of producing the system. |
08/23/1995 | EP0667767A1 Method for the preparation of creams |
08/23/1995 | EP0297109B1 Process for the preparation of a viscosity-stable antacid composition |
08/23/1995 | CN1107069A Natural lipophilic surfactant-yolk phospholipid 6 and preparing method |
08/23/1995 | CN1107042A Inclusion complex |
08/23/1995 | CN1107041A Transmucosal delivery of macromolecular drugs |
08/23/1995 | CN1029541C Nutritional composition and process for its production |
08/22/1995 | US5444150 For use in solid phase peptide synthesis for introducing side chain bromoacetyl group |
08/22/1995 | US5444096 Stable anhydrous topically-active composition and suspending agent therefor |
08/22/1995 | US5444076 Pharmaceutical preparation for topical application |
08/22/1995 | US5444075 Penetration enhancers for transdermal delivery of systemic agents |
08/22/1995 | US5444052 Synergistic mixture with a glycerol ether |
08/22/1995 | US5444041 Convertible microemulsion formulations |
08/22/1995 | US5443967 DNA encoding the cancer associated SCM recognition factor |
08/22/1995 | US5443846 Granulated preparations and method of producing the same |
08/22/1995 | US5443842 Mixed with isopropyl myristate or palmitate and polyethoxy-lated, hydrogenated castor oils |
08/22/1995 | US5443840 Cosmetic and/or pharmaceutical composition containing a dispersion of lipid vesicles, process for the preparation of the said dispersion and dispersion of lipid vesicles |
08/22/1995 | US5443832 Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response |
08/22/1995 | US5443829 For enhancing delivery of drugs across mucous membranes of animals |
08/22/1995 | US5443827 Chimeric molecule; anticoagulants |
08/22/1995 | US5443824 Soluble in polyethylene glycol having molecular weight range from 200 to 600; widely used in treatment of connective tissue diseases, inflammatory skin, disorder of keratinization, bullous skin disorder, conjunctiva and leprosy |
08/22/1995 | US5443814 X-ray contrast compositions containing iodophenoxyalkanes and cellulose derivatives |
08/22/1995 | US5443727 Thin, self-interlocking, tactic, hydrophilic polyvinyl alcohol enveloping the surfaces, retaining complex geometric configuration |
08/22/1995 | CA1336760C Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells |
08/17/1995 | WO1995021931A1 Nucleic acid-containing composition, its preparation and use |
08/17/1995 | WO1995021870A1 Method for the preparation of branched cyclomaltooligosaccharides, in particular, branched cyclodextrines |
08/17/1995 | WO1995021866A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain |
08/17/1995 | WO1995021865A1 Immunointeractive molecules-i |
08/17/1995 | WO1995021845A1 Texaphyrin metal complexes having improved functionalization |
08/17/1995 | WO1995021629A1 Oral delivery of chemically modified proteins |
08/17/1995 | WO1995021628A1 Treatment of antibiotic associated diarrhea |
08/17/1995 | WO1995021623A1 Peptides and methods against diabetes |
08/17/1995 | WO1995021622A1 Gel-forming polypeptide derivatives |